Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.
第一作者:
Gary J,Grover
第一单位:
Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Pennington, NJ 08534, USA. groverg@bms.com
作者:
主题词
动物(Animals);抗胆固醇血症药(Anticholesteremic Agents);心血管系统(Cardiovascular System);胆固醇(Cholesterol);胆固醇, 膳食(Cholesterol, Dietary);人类(Humans);动力学(Kinetics);脂蛋白(A)(Lipoprotein(a));成束猴(Macaca fascicularis);小鼠(Mice);小鼠, 基因敲除(Mice, Knockout);苯乙醚类(Phenyl Ethers);苯乙酸酯类(Phenylacetates);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, 甲状腺激素(Receptors, Thyroid Hormone);甲状腺激素受体α(Thyroid Hormone Receptors alpha);甲状腺激素受体β(Thyroid Hormone Receptors beta);三碘甲状腺原氨酸(Triiodothyronine);体重减轻(Weight Loss)
DOI
10.1073/pnas.1633737100
PMID
12888625
发布时间
2024-04-10
- 浏览22

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文